Brochure
9 Oct 2019
Bioanalysis Testing Solutions
PDF 1.2 MB
With over 30 years of experience and operating out of our GLP/GCP compliant laboratories. SGS has the expertise to both develop assays from scratch (including LC-MS/MS, immunoassays and cell-based assays) and to support large scale routine sample analyses, from regulatory pre-clinical (toxicology) to early and late clinical studies (Phase I to IV).
Content provided by our supplier
SGS North America Inc.
-
Country/Region:United States
-
On CPHI since:2015
Other Content from SGS North America Inc. (1)
-
Video Multi-Attribute Method: An Emerging Platform for Product Development
A review of various methods and instrumentation, including the benefits and limitations for each in biomanufacturing. Regulatory views, including description of use/acceptance at each phase of drug discovery from pre-clinical through BLA. Case Study.